CS250249B2 - Method of imidazole's tricyclic derivatives production - Google Patents

Method of imidazole's tricyclic derivatives production Download PDF

Info

Publication number
CS250249B2
CS250249B2 CS856644A CS664485A CS250249B2 CS 250249 B2 CS250249 B2 CS 250249B2 CS 856644 A CS856644 A CS 856644A CS 664485 A CS664485 A CS 664485A CS 250249 B2 CS250249 B2 CS 250249B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
methyl
pyridyl
give
compound
Prior art date
Application number
CS856644A
Other languages
Czech (cs)
English (en)
Inventor
Albert Fischli
Anna Krasso
Henri Ramuz
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS250249B2 publication Critical patent/CS250249B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS856644A 1984-04-19 1985-04-16 Method of imidazole's tricyclic derivatives production CS250249B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH196684 1984-04-19

Publications (1)

Publication Number Publication Date
CS250249B2 true CS250249B2 (en) 1987-04-16

Family

ID=4222776

Family Applications (2)

Application Number Title Priority Date Filing Date
CS856644A CS250249B2 (en) 1984-04-19 1985-04-16 Method of imidazole's tricyclic derivatives production
CS852800A CS250248B2 (en) 1984-04-19 1985-04-16 Method of imidazole's tricyclic derivatives production

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS852800A CS250248B2 (en) 1984-04-19 1985-04-16 Method of imidazole's tricyclic derivatives production

Country Status (21)

Country Link
US (2) US4634710A (mo)
EP (1) EP0163842A1 (mo)
JP (1) JPS60233070A (mo)
KR (1) KR850007256A (mo)
AU (1) AU589555B2 (mo)
CS (2) CS250249B2 (mo)
DD (1) DD232277A5 (mo)
DK (1) DK148585A (mo)
ES (4) ES8607963A1 (mo)
FI (1) FI851431A7 (mo)
GR (1) GR850949B (mo)
HU (1) HU193362B (mo)
IL (1) IL74880A (mo)
MC (1) MC1650A1 (mo)
NO (1) NO162617C (mo)
NZ (1) NZ211773A (mo)
PH (1) PH21046A (mo)
PT (1) PT80315B (mo)
SU (2) SU1362402A3 (mo)
ZA (1) ZA852765B (mo)
ZW (1) ZW4585A1 (mo)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
CA2195444A1 (en) * 1994-07-20 1996-02-01 Bernhard Kohl Thiopyridyl compounds for controlling helicobacter bacteria
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
PL2003130T3 (pl) * 2006-03-10 2012-04-30 Link Genomics Inc Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori
RU2487126C1 (ru) * 2011-11-28 2013-07-10 Открытое акционерное общество "Федеральный научно-производственный центр "Алтай" Способ получения 1,4-диоксан-2,3-диола

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1805548A1 (de) * 1968-10-26 1970-10-08 Agfa Gevaert Ag Benzimidazol-Derivate und ihre photographische Verwendung
IN148930B (mo) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
HU193408B (en) * 1983-05-03 1987-10-28 Byk Gulden Lomberg Chem Fqb Process for production of new tree-cycle compounds
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
AU589555B2 (en) 1989-10-19
PT80315B (en) 1987-03-16
ES551472A0 (es) 1987-06-01
ES8706128A1 (es) 1987-06-01
NO162617B (no) 1989-10-16
MC1650A1 (fr) 1986-04-07
ZA852765B (en) 1985-11-27
NO162617C (no) 1990-01-24
CS250248B2 (en) 1987-04-16
ES542370A0 (es) 1986-06-16
US4981861A (en) 1991-01-01
JPS60233070A (ja) 1985-11-19
NO851550L (no) 1985-10-21
ES551471A0 (es) 1987-06-01
HUT37613A (en) 1986-01-23
KR850007256A (ko) 1985-12-02
ES8706124A1 (es) 1987-06-01
AU4122885A (en) 1985-10-24
GR850949B (mo) 1985-11-25
DD232277A5 (de) 1986-01-22
FI851431L (fi) 1985-10-20
FI851431A7 (fi) 1985-10-20
DK148585D0 (da) 1985-04-01
HU193362B (en) 1987-09-28
IL74880A (en) 1988-06-30
PT80315A (en) 1985-05-01
US4634710A (en) 1987-01-06
ES8706129A1 (es) 1987-06-01
FI851431A0 (fi) 1985-04-10
EP0163842A1 (de) 1985-12-11
ES551473A0 (es) 1987-06-01
NZ211773A (en) 1989-01-06
ZW4585A1 (en) 1985-11-20
DK148585A (da) 1985-10-20
SU1396965A3 (ru) 1988-05-15
PH21046A (en) 1987-07-03
IL74880A0 (en) 1985-07-31
SU1362402A3 (ru) 1987-12-23
ES8607963A1 (es) 1986-06-16

Similar Documents

Publication Publication Date Title
EP0654471B1 (en) Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same
EP0005129B1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
US5703097A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
US4175127A (en) Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
HU176111B (en) Process for preparing methylthio-naphtimidazole derivatives substituted with a heterocyclic group
JPS63146882A (ja) イミダゾ[4,5―b]ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
EP0601386A1 (de) Neue Sulfonamide
JPH0674272B2 (ja) ピリジン誘導体及びそれを含有する潰瘍治療剤
EP0116769B1 (en) Dihydropyridines
HU197330B (en) Process for preparing thienoimidazole derivatives and pharmaceuticals comprising the same
KR910002824B1 (ko) 피리딘유도체 및 그것을 함유하는 궤양치료제
KR900003368B1 (ko) 신규한 인데노티아졸 유도체의 제조방법
EP0184322A1 (en) Benzimidazoles
CS250248B2 (en) Method of imidazole's tricyclic derivatives production
NO863228L (no) Fremgangsmaate for fremstilling av farmakodynamisk aktive benzimidazol-derivater.
JPS63502658A (ja) 新規な物質の組成
EP0683776B1 (de) Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien
FI80458C (fi) Foerfarande foer framstaellning av . terapeutiskt anvaendbara tiazolo/3,2-a/bensimidazoler och 2,3-dihydroanaloger daerav.
US4873237A (en) 2,3-dihydro- thiazolo- and thiazino- benzimidazoles as atni-hyper secretion agents
US4076717A (en) Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
JP2779206B2 (ja) スルフェンアミド誘導体
JP2524420B2 (ja) ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
JPH0633261B2 (ja) 新規なイミダゾ[4,5−bピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
JP2766309B2 (ja) ピリジニウム誘導体
EP0206623B1 (en) Pyridine derivatives